Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |